CMS updates drug dashboards with prescription drug pricing and spending data

CMS reports that it updated its Drug Spending Dashboards with data for 2017. The dashboards, first released in May 2018, add information on the manufacturers that are responsible for prices hikes and include pricing and spending data for thousands of drugs across Medicare Parts B and D and Medicaid.

CMS reports that it updated its Drug Spending Dashboards with data for 2017. The dashboards, first released in May 2018, add information on the manufacturers that are responsible for prices hikes and include pricing and spending data for thousands of drugs across Medicare Parts B and D and Medicaid. An interactive web-based tool enables researchers and consumers to easily sort the dashboard data to identify trends. "The dashboards pinpoint the sources of rising prescription drug prices to help guide our continued work to address this problem," said CMS Administrator Seema Verma. "From 2013–17, prescription drug spending grew at an average annual rate of 10.6% in Medicare Part D, 10.0% in Part B, and 14.8% in Medicaid—this is one of our fastest areas of growth." Total gross spending on prescription drugs in 2017 totaled $154.9 billion in Medicare Part D, $30.4 billion in Part B, and $67.6 billion in Medicaid.